CD4 and rheumatoid arthritis: When lymphocyte subpopulations were analyzed, although no significant differences were found between RA patients and healthy volunteers, lower percentages were found in remission subjects vs. ERA (p < 0.05) and flare-up (p < 0.01) of both T (CD3+) and CD3+CD4− lymphocytes (Figure 2B,C).